Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

173896 ARTíCULOS , VIENDO DEL 173416 AL 173430

PUBMED

An elevated leg movement index during sleep in atopic dermatitis and periodic leg movement disorder may be an indication of sympathetic activation common to both

Gupta MA, Gupta AK.

J Clin Sleep Med. 2020 Mar 15;16(3):463. doi: 10.5664/jcsm.8234. Epub 2020 Jan 14.

0

0

0

PUBMED

POLR3A variants with striatal involvement and extrapyramidal movement disorder

Harting I, Al-Saady M, Krägeloh-Mann I, Bley A, Hempel M, Bierhals T, Karch S, Moog U, Bernard G, Huntsman R, van Spaendonk RML, Vreeburg M, Rodríguez-Palmero A, Pujol A, van der Knaap MS, Pouwels PJW

Neurogenetics. 2020 Apr;21(2):121-133. doi: 10.1007/s10048-019-00602-4. Epub 2020 Jan 15.

0

0

0

PUBMED

Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone

Larrivee CL, Feng H, Quinn JA, Shaw VS, Leipprandt JR, Demireva EY, Xie H, Neubig RR.

J Pharmacol Exp Ther. 2020 Apr;373(1):24-33. doi: 10.1124/jpet.119.262733. Epub 2020 Jan 6.

0

0

0

PUBMED

Forelimb Movement Disorder in Rat Experimental Model.

Marešová D, Kotková K, Kozler P, Pokorný J.

Physiol Res. 2019 Dec 30;68(6):1037-1042. Epub 2019 Oct 25.

0

0

0

PUBMED

The movement disorder society nonmotor rating scale: Initial validation study

Chaudhuri KR, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Mamikonyan E, Martinez-Martin P.

Mov Disord. 2020 Jan;35(1):116-133. doi: 10.1002/mds.27862. Epub 2019 Sep 30.

0

0

0

PUBMED

Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies

Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Roeber S, Giese A, Grossman M, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C

Mov Disord. 2020 Jan;35(1):171-176. doi: 10.1002/mds.27872. Epub 2019 Sep 30.

0

0

0

PUBMED

Noninvasive and quantitative evaluation of movement disorder disability using an infrared depth sensor

Tsukagoshi S, Furuta M, Hirayanagi K, Furuta N, Nakazato S, Fujii M, Yuminaka Y, Ikeda Y.

J Clin Neurosci. 2020 Jan;71:135-140. doi: 10.1016/j.jocn.2019.08.101. Epub 2019 Sep 26.

0

0

0

PUBMED

Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease

Reuland CJ, Church FC.

Med Hypotheses. 2020 May;138:109602. doi: 10.1016/j.mehy.2020.109602. Epub 2020 Jan 28.

0

0

0

PUBMED

Quantitative assessment of posture in healthy controls and patients with Parkinson's disease

Schlenstedt C, Boße K, Gavriliuc O, Wolke R, Granert O, Deuschl G, Margraf NG.

Parkinsonism Relat Disord. 2020 Jan 28:S1353-8020(20)30022-5. doi: 10.1016/j.parkreldis.2020.01.012. Online ahead of print.

0

0

0

PUBMED

A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy

Scarpa A, Cassandro C, Vitale C, Ralli M, Policastro A, Barone P, Cassandro E, Pellecchia MT.

Parkinsonism Relat Disord. 2020 Feb;71:51-57. doi: 10.1016/j.parkreldis.2020.01.018. Epub 2020 Jan 30.

0

0

0

PUBMED

Early diagnosis of Parkinson's disease using machine learning algorithms

Karapinar Senturk Z.

Med Hypotheses. 2020 May;138:109603. doi: 10.1016/j.mehy.2020.109603. Epub 2020 Jan 27.

0

0

0

PUBMED

Identification of potential natural neuroprotective molecules for Parkinson's disease by using chemoinformatics and molecular docking

Rondón-Villarreal P, López WOC.

J Mol Graph Model. 2020 Jun;97:107547. doi: 10.1016/j.jmgm.2020.107547. Epub 2020 Jan 24.

0

0

0

PUBMED

Incidence of Free of Charge Physiotherapy in a Danish National Cohort of Stroke, Parkinson's Disease, Multiple Sclerosis and Rheumatoid Arthritis Patients

Næss-Schmidt ET, Christiansen DH, Østgård RD, Andersen NV, Nielsen JF, Odgaard L.

Clin Epidemiol. 2020 Jan 14;12:23-29. doi: 10.2147/CLEP.S223000. eCollection 2020.

0

0

0

PUBMED

Neuroprotective effects of Danshensu on rotenone-induced Parkinson's disease models in vitro and in vivo

Wang T, Li C, Han B, Wang Z, Meng X, Zhang L, He J, Fu F.

BMC Complement Med Ther. 2020 Jan 23;20(1):20. doi: 10.1186/s12906-019-2738-7.

0

0

0

PUBMED

Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model

Ugalde-Muñiz P, Fetter-Pruneda I, Navarro L, García E, Chavarría A.

Oxid Med Cell Longev. 2020 Jan 13;2020:4807179. doi: 10.1155/2020/4807179. eCollection 2020.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy